Pacific Biosciences of California PACB Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's investing cash flow?
- Pacific Biosciences of California (PACB) reported investing cash flow of $35.86M in Q1 2026.
- How has Pacific Biosciences of California's investing cash flow changed year-over-year?
- Pacific Biosciences of California's investing cash flow decreased by 20.7% year-over-year, from $45.23M to $35.86M.
- What is the long-term trend for Pacific Biosciences of California's investing cash flow?
- Over 3 years (2021 to 2025), Pacific Biosciences of California's investing cash flow has grown at a -46.3% compound annual growth rate (CAGR), from -$744.28M to $115.45M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.